AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. K
  4. [Form 4] Kellanova Insider Trading Activity

[Form 4] Kellanova Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Negative)
Form Type
4
Rhea-AI Filing Summary

The W.K. Kellogg Foundation Trust reported a sale of 114,583 shares of Kellanova common stock on 08/07/2025 at an aggregate price of $79.97 per share. After the reported transaction, the Trust and related Foundation beneficially owned 45,441,203 shares.

The filing identifies the Trust as the reporting person with trustees named and the W.K. Kellogg Foundation as sole beneficiary. The sale was executed pursuant to trading instructions given on May 7, 2024 that are intended to comply with Rule 10b5-1(c), and the Form 4 discloses the transaction and resulting holdings.

Il W.K. Kellogg Foundation Trust ha segnalato la vendita di 114,583 azioni ordinarie di Kellanova il 08/07/2025 a un prezzo unitario di $79.97. Dopo l'operazione segnalata, il Trust e la relativa Foundation detenevano beneficiariamente 45,441,203 azioni.

La comunicazione indica il Trust come soggetto segnalante, con i trustee nominati e la W.K. Kellogg Foundation quale unico beneficiario. La vendita 猫 stata eseguita in base a istruzioni di negoziazione impartite il 7 maggio 2024 dirette a rispettare la Regola 10b5-1(c), e il Modulo 4 riporta la transazione e le partecipazioni risultanti.

El W.K. Kellogg Foundation Trust inform贸 la venta de 114,583 acciones ordinarias de Kellanova el 08/07/2025 a un precio por acci贸n de $79.97. Tras la transacci贸n informada, el Trust y la Fundaci贸n relacionada pose铆an de forma beneficiaria 45,441,203 acciones.

La presentaci贸n identifica al Trust como la persona informante, con los fideicomisarios nombrados y la W.K. Kellogg Foundation como 煤nico beneficiario. La venta se ejecut贸 conforme a instrucciones de negociaci贸n dadas el 7 de mayo de 2024 destinadas a cumplir la Norma 10b5-1(c), y el Formulario 4 declara la transacci贸n y las participaciones resultantes.

W.K. Kellogg Foundation Trust電� 08/07/2025鞐� Kellanova 氤错喌欤� 114,583欤茧ゼ 欤茧嫻 $79.97鞚� 臧�瓴╈溂搿� 毵る弰頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 鞁犼碃霅� 瓯半灅 鞚错泟 Trust 氚� 甏�霠� 鞛嫧鞚� 靾橃澋鞝� 靻岇湢搿滌劀 45,441,203欤茧ゼ 氤挫湢頃橁碃 鞛堨姷雼堧嫟.

鞁犼碃靹滌棎電� 氤搓碃鞚胳溂搿� Trust臧� 氇呾嫓霅橃柎 鞛堨溂氅�, 鞁犿儊甏�毽澑霌れ澊 旮办灛霅橁碃 W.K. Kellogg Foundation鞚� 雼弲 靾橃澋鞛愲 歆�鞝曤悩鞏� 鞛堨姷雼堧嫟. 頃措嫻 毵る弰電� 2024雲� 5鞗� 7鞚�鞐� 雮措牑歆� 瓯半灅 歆�旃棎 霐半澕 鞁ろ枆霅橃棃鞙茧┌ 鞚措姅 攴滌箼 10b5-1(c)鞚� 欷�靾橅晿旮� 鞙勴暅 瓴冹瀰雼堧嫟. Form 4鞐愲姅 頃措嫻 瓯半灅鞕� 攴胳棎 霐半ジ 氤挫湢 雮挫棴鞚� 瓿店皽霅橃柎 鞛堨姷雼堧嫟.

Le W.K. Kellogg Foundation Trust a d茅clar茅 la vente de 114,583 actions ordinaires de Kellanova le 08/07/2025 au prix unitaire de $79.97. Apr猫s la transaction d茅clar茅e, le Trust et la Fondation affili茅e d茅tenaient b茅n茅ficiairement 45,441,203 actions.

Le d茅p么t identifie le Trust comme la personne d茅clarante, avec les trustees nomm茅s et la W.K. Kellogg Foundation comme unique b茅n茅ficiaire. La vente a 茅t茅 ex茅cut茅e en vertu d'instructions de n茅gociation donn茅es le 7 mai 2024 visant 脿 se conformer 脿 la r猫gle 10b5-1(c), et le formulaire 4 divulgue la transaction ainsi que les participations r茅sultantes.

Der W.K. Kellogg Foundation Trust meldete den Verkauf von 114,583 Stammaktien von Kellanova am 08/07/2025 zu einem Preis von $79.97 pro Aktie. Nach der gemeldeten Transaktion besa脽en der Trust und die zugeh枚rige Stiftung wirtschaftlich 45,441,203 Aktien.

Die Meldung benennt den Trust als meldende Person, nennt die Treuh盲nder und nennt die W.K. Kellogg Foundation als alleinigen Beg眉nstigten. Der Verkauf wurde gem盲脽 Handelsanweisungen durchgef眉hrt, die am 7. Mai 2024 erteilt wurden und darauf abzielen, Regel 10b5-1(c) zu erf眉llen; Formular 4 legt die Transaktion und die daraus resultierenden Best盲nde offen.

Positive
  • Transaction executed under a documented Rule 10b5-1(c) plan, indicating pre-established trading instructions and procedural compliance
  • Clear disclosure of post-transaction holdings with the Trust retaining 45,441,203 shares after the sale
Negative
  • None.

Insights

TL;DR: Trustee sale disclosed under a 10b5-1 plan; filing shows compliance and substantial retained ownership.

The Form 4 documents a trustee-authorized sale of 114,583 shares at $79.97, executed under pre-established trading instructions intended to satisfy Rule 10b5-1(c). From a governance standpoint, use of a 10b5-1 plan and clear disclosure in Form 4 demonstrate procedural compliance and transparency by the Trust and its corporate trustee. The filing also shows the Trust continues to hold a large position鈥�45,441,203 shares鈥攁fter the sale, which limits interpretive weight of this single transaction.

TL;DR: A routine trustee sale under a 10b5-1 plan; transaction size appears modest relative to remaining holdings.

For investors, the key facts are the sale quantity (114,583 shares) and price ($79.97), and that the transaction was carried out under a documented trading instruction dated May 7, 2024. The Form 4 confirms continued sizeable ownership by the Trust (45,441,203 shares), indicating this single sale does not materially reduce the Trust's stake. The disclosure is timely and standard for trustee-managed sales.

Il W.K. Kellogg Foundation Trust ha segnalato la vendita di 114,583 azioni ordinarie di Kellanova il 08/07/2025 a un prezzo unitario di $79.97. Dopo l'operazione segnalata, il Trust e la relativa Foundation detenevano beneficiariamente 45,441,203 azioni.

La comunicazione indica il Trust come soggetto segnalante, con i trustee nominati e la W.K. Kellogg Foundation quale unico beneficiario. La vendita 猫 stata eseguita in base a istruzioni di negoziazione impartite il 7 maggio 2024 dirette a rispettare la Regola 10b5-1(c), e il Modulo 4 riporta la transazione e le partecipazioni risultanti.

El W.K. Kellogg Foundation Trust inform贸 la venta de 114,583 acciones ordinarias de Kellanova el 08/07/2025 a un precio por acci贸n de $79.97. Tras la transacci贸n informada, el Trust y la Fundaci贸n relacionada pose铆an de forma beneficiaria 45,441,203 acciones.

La presentaci贸n identifica al Trust como la persona informante, con los fideicomisarios nombrados y la W.K. Kellogg Foundation como 煤nico beneficiario. La venta se ejecut贸 conforme a instrucciones de negociaci贸n dadas el 7 de mayo de 2024 destinadas a cumplir la Norma 10b5-1(c), y el Formulario 4 declara la transacci贸n y las participaciones resultantes.

W.K. Kellogg Foundation Trust電� 08/07/2025鞐� Kellanova 氤错喌欤� 114,583欤茧ゼ 欤茧嫻 $79.97鞚� 臧�瓴╈溂搿� 毵る弰頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 鞁犼碃霅� 瓯半灅 鞚错泟 Trust 氚� 甏�霠� 鞛嫧鞚� 靾橃澋鞝� 靻岇湢搿滌劀 45,441,203欤茧ゼ 氤挫湢頃橁碃 鞛堨姷雼堧嫟.

鞁犼碃靹滌棎電� 氤搓碃鞚胳溂搿� Trust臧� 氇呾嫓霅橃柎 鞛堨溂氅�, 鞁犿儊甏�毽澑霌れ澊 旮办灛霅橁碃 W.K. Kellogg Foundation鞚� 雼弲 靾橃澋鞛愲 歆�鞝曤悩鞏� 鞛堨姷雼堧嫟. 頃措嫻 毵る弰電� 2024雲� 5鞗� 7鞚�鞐� 雮措牑歆� 瓯半灅 歆�旃棎 霐半澕 鞁ろ枆霅橃棃鞙茧┌ 鞚措姅 攴滌箼 10b5-1(c)鞚� 欷�靾橅晿旮� 鞙勴暅 瓴冹瀰雼堧嫟. Form 4鞐愲姅 頃措嫻 瓯半灅鞕� 攴胳棎 霐半ジ 氤挫湢 雮挫棴鞚� 瓿店皽霅橃柎 鞛堨姷雼堧嫟.

Le W.K. Kellogg Foundation Trust a d茅clar茅 la vente de 114,583 actions ordinaires de Kellanova le 08/07/2025 au prix unitaire de $79.97. Apr猫s la transaction d茅clar茅e, le Trust et la Fondation affili茅e d茅tenaient b茅n茅ficiairement 45,441,203 actions.

Le d茅p么t identifie le Trust comme la personne d茅clarante, avec les trustees nomm茅s et la W.K. Kellogg Foundation comme unique b茅n茅ficiaire. La vente a 茅t茅 ex茅cut茅e en vertu d'instructions de n茅gociation donn茅es le 7 mai 2024 visant 脿 se conformer 脿 la r猫gle 10b5-1(c), et le formulaire 4 divulgue la transaction ainsi que les participations r茅sultantes.

Der W.K. Kellogg Foundation Trust meldete den Verkauf von 114,583 Stammaktien von Kellanova am 08/07/2025 zu einem Preis von $79.97 pro Aktie. Nach der gemeldeten Transaktion besa脽en der Trust und die zugeh枚rige Stiftung wirtschaftlich 45,441,203 Aktien.

Die Meldung benennt den Trust als meldende Person, nennt die Treuh盲nder und nennt die W.K. Kellogg Foundation als alleinigen Beg眉nstigten. Der Verkauf wurde gem盲脽 Handelsanweisungen durchgef眉hrt, die am 7. Mai 2024 erteilt wurden und darauf abzielen, Regel 10b5-1(c) zu erf眉llen; Formular 4 legt die Transaktion und die daraus resultierenden Best盲nde offen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KELLOGG W K FOUNDATION TRUST
(Last) (First) (Middle)
ONE MICHIGAN AVE. EAST
(Street)
BATTLE CREEK MI 49017
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
KELLANOVA [ K ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/07/2025 08/07/2025 S 114,583 D $79.97 45,441,203(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
KELLOGG W K FOUNDATION TRUST
(Last) (First) (Middle)
ONE MICHIGAN AVE. EAST
(Street)
BATTLE CREEK MI 49017
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
KELLOGG W K FOUNDATION
(Last) (First) (Middle)
ONE MICHIGAN AVENUE EAST
(Street)
BATTLE CREEK MI 49017
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. 45,441,203 shares were owned following the reported transaction by the W.K. Kellogg Foundation Trust (the "Trust") of which LaJune Montgomery Tabron, Steve Cahillane, Richard M. Tsoumas and The Northern Trust Company are Trustees and the W.K. Kellogg Foundation (the "Foundation") is the sole beneficiary.
Remarks:
The sales reported on this Form 4 were made pursuant to trading instructions given by the W.K. Kellogg Foundation Trust on May 7, 2024 that are intended to comply with Rule 10b5-1(c) under the Securities and Exchange Act of 1934.
Craig R. Carberry, Deputy General Counsel, The Northern Trust Company, as Corporate Trustee of the W.K. Kellogg Foundation Trust and signing for the W.K. Kellogg Foundation pursuant to a Power of Attorney dated August 30, 2017 08/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What did the W.K. Kellogg Foundation Trust report on Form 4 for Kellanova (K)?

The Trust reported a sale of 114,583 shares of Kellanova common stock on 08/07/2025 at $79.97 per share.

How many Kellanova (K) shares did the Trust hold after the reported sale?

Following the transaction the Trust beneficially owned 45,441,203 shares.

Was the sale by the Trust part of a 10b5-1 trading plan?

Yes. The filing states the sales were made pursuant to trading instructions dated May 7, 2024 intended to comply with Rule 10b5-1(c).

Who is the reporting person on the Form 4?

The reporting persons are the W.K. Kellogg Foundation Trust and the W.K. Kellogg Foundation, with The Northern Trust Company acting as corporate trustee.

What price per share was reported for the transaction?

The reported price was $79.97 per share.

When was the Form 4 signed and by whom?

The Form 4 was signed by Craig R. Carberry, Deputy General Counsel, The Northern Trust Company, as Corporate Trustee on behalf of the Trust.
Stock K logo
Kellanova

NYSE:K

K Rankings

#634 Ranked by Market Cap
#1152 Ranked by Dividends

K Latest News

Aug 6, 2025
U.S. Soccer Federation and Kellanova Come Together to Celebrate the Team Spirit at the Heart of Soccer in New National Partnership
Jul 31, 2025
Kellanova Reports 2025 Second Quarter Results
Jul 25, 2025
Kellanova Declares Regular Dividend of $0.58 per Share for Third Quarter
Jul 21, 2025
Nutri-Grain Launches "Not Sorry" Campaign with AG真人官方ity TV's Most Unapologetic Stars
Jul 14, 2025
CHEEZ-IT庐 BRINGS ITS A-GAME TO THE BASKETBALL 'TUNNEL FIT' TREND WITH SNACK-INSPIRED PIECES

K Latest SEC Filings

Aug 7, 2025
[144] Kellanova SEC Filing
Jul 31, 2025
[10-Q] Kellanova Quarterly Earnings Report
Jul 31, 2025
[8-K] Kellanova Reports Material Event
Jul 30, 2025
[144] Kellanova SEC Filing
Jul 28, 2025
[Form 4] Kellanova Insider Trading Activity

K Stock Data

27.76B
346.05M
0.51%
82%
3.01%
Packaged Foods
Grain Mill Products
United States
CHICAGO